Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

27.42CAD
18 Jan 2018
Change (% chg)

$-0.83 (-2.94%)
Prev Close
$28.25
Open
$28.25
Day's High
$28.25
Day's Low
$26.88
Volume
1,902,886
Avg. Vol
1,975,631
52-wk High
$30.56
52-wk Low
$11.20

Select another date:

BRIEF-Valeant Pays Down $300 Million Of Senior Secured Term Loans

Jan 3 Valeant Pharmaceuticals International Inc :

Pershing Square, Valeant to appear in court on insider trading suit settlement

A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

UPDATE 1-Pershing Square, Valeant to appear in court on insider trading suit settlement

Jan 2 A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

Pershing Square, Valeant asked to appear for hearing on insider trading suit

Jan 2 A U.S. court on Tuesday asked Valeant Pharmaceuticals International Inc and activist investor Bill Ackman's Pershing Square to appear for a hearing to discuss the proposed settlement in an insider trading lawsuit.

BRIEF-Pershing Square Holdings Announces Agreement To Settle Lawsuits Related To Allergan

* PERSHING SQUARE WILL PAY $193.75 MILLION AND VALEANT WILL PAY $96.25 MILLION

Pershing Square, Valeant arrive at settlement split for Allergan lawsuit

Activist investor William Ackman's Pershing Square and Valeant Pharmaceuticals on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc in 2014.

UPDATE 1-Pershing Square, Valeant arrive at settlement split for Allergan lawsuit

Dec 29 Activist investor William Ackman's Pershing Square and Valeant Pharmaceuticals on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc in 2014.

Pershing Square and Valeant reach agreement on settlement split

Dec 29 Activist investor William Ackman's Pershing Square said on Friday it had reached an agreement with Valeant Pharmaceuticals to split settlement costs of a lawsuit related to Allergan Plc.

Select another date: